Summit Therapeutics Stock Options Expiring on 19th of December 2025
| SMMT Stock | USD 18.79 0.82 4.56% |
Summit Therapeutics' latest option contracts expiring on 2025-12-19 are carrying combined implied volatility of 0.38 with a put-to-call open interest ratio of 5.0 over 30 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on 2025-12-19. The total put volume is at 309, with calls trading at the volume of 309. This yields a 2.78 put-to-call volume ratio.
Open Interest Against 2025-12-19 Option Contracts
Summit Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Summit Therapeutics' lending market. For example, when Summit Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Summit Therapeutics, he or she must hedge the risk by shorting Summit Therapeutics stock over its option's life.
2025-12-19
The chart above shows Summit Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Summit Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Summit Therapeutics' option, there is no secondary market available for investors to trade.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Summit Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. Summit Therapeutics PLC In The Money Call Balance
When Summit Therapeutics' strike price is surpassing the current stock price, the option contract against Summit Therapeutics PLC stock is said to be in the money. When it comes to buying Summit Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Summit Therapeutics PLC are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Summit Current Options Market Mood
Summit Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Summit Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Summit Therapeutics' options investors are not very successful. Summit Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Summit contract
Base on the Rule 16, the options market is currently suggesting that Summit Therapeutics PLC will have an average daily up or down price movement of about 0.0238% per day over the life of the 2025-12-19 option contract. With Summit Therapeutics trading at USD 18.79, that is roughly USD 0.004463. If you think that the market is fully incorporating Summit Therapeutics' daily price movement you should consider buying Summit Therapeutics PLC options at the current volatility level of 0.38%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Summit |
Summit Therapeutics Option Chain
When Summit Therapeutics' strike price is surpassing the current stock price, the option contract against Summit Therapeutics PLC stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2024-12-132024-12-202024-12-272025-01-032025-01-102025-01-172025-01-242025-04-172025-07-182025-09-192025-12-192026-01-162027-01-15
Summit Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Summit. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Summit. It also shows strike prices and maturity days for a Summit Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | SMMT Option Call 19-12-2025 4 | 0 | 2025-12-19 | 0.0 - 0.0 | 16.04 | In |
Call | SMMT Option Call 19-12-2025 5 | 0 | 2025-12-19 | 0.0 - 0.0 | 15.23 | In |
Call | SMMT Option Call 19-12-2025 7 | 0 | 2025-12-19 | 0.0 - 0.0 | 13.3 | In |
Call | SMMT Option Call 19-12-2025 10 | 0 | 2025-12-19 | 0.0 - 0.0 | 10.5 | In |
Call | SMMT Option Call 19-12-2025 12 | 0 | 2025-12-19 | 0.0 - 0.0 | 10.15 | In |
Call | SMMT Option Call 19-12-2025 15 | 0 | 2025-12-19 | 0.0 - 0.0 | 10.22 | In |
Call | SMMT Option Call 19-12-2025 17 | 0 | 2025-12-19 | 0.0 - 0.0 | 7.38 | In |
Call | SMMT Option Call 19-12-2025 20 | 0 | 2025-12-19 | 0.0 - 0.0 | 6.1 | |
Call | SMMT Option Call 19-12-2025 22 | 0 | 2025-12-19 | 0.0 - 0.0 | 6.34 | |
Call | SMMT Option Call 19-12-2025 25 | 0 | 2025-12-19 | 0.0 - 0.0 | 4.43 | |
Call | SMMT Option Call 19-12-2025 27 | 29 | 2025-12-19 | 4.6 - 5.4 | 8.78 | Out |
Call | SMMT Option Call 19-12-2025 30 | 0 | 2025-12-19 | 0.0 - 0.0 | 4.22 | |
Call | SMMT Option Call 19-12-2025 32 | 0 | 2025-12-19 | 0.0 - 0.0 | 3.97 | |
Call | SMMT Option Call 19-12-2025 35 | 60 | 2025-12-19 | 3.5 - 5.6 | 5.8 | Out |
Call | SMMT Option Call 19-12-2025 37 | 0 | 2025-12-19 | 0.0 - 0.0 | 4.8 | |
Call | SMMT Option Call 19-12-2025 40 | 0 | 2025-12-19 | 0.0 - 0.0 | 2.65 | |
Call | SMMT Option Call 19-12-2025 45 | 1 | 2025-12-19 | 2.85 - 4.6 | 4.05 | Out |
Call | SMMT Option Call 19-12-2025 47 | 1 | 2025-12-19 | 4.3 - 5.8 | 7.1 | Out |
Call | SMMT Option Call 19-12-2025 50 | 0 | 2025-12-19 | 0.0 - 0.0 | 1.97 | |
Put | SMMT Option Put 19-12-2025 10 | 0 | 2025-12-19 | 0.0 - 0.0 | 1.7 | |
Put | SMMT Option Put 19-12-2025 12 | 0 | 2025-12-19 | 0.0 - 0.0 | 2.53 | |
Put | SMMT Option Put 19-12-2025 15 | 3 | 2025-12-19 | 3.4 - 5.2 | 4.37 | Out |
Put | SMMT Option Put 19-12-2025 17 | 0 | 2025-12-19 | 0.0 - 0.0 | 5.2 | |
Put | SMMT Option Put 19-12-2025 20 | 0 | 2025-12-19 | 0.0 - 0.0 | 6.8 | In |
Put | SMMT Option Put 19-12-2025 22 | 0 | 2025-12-19 | 6.2 - 10.7 | 8.88 | In |
Put | SMMT Option Put 19-12-2025 25 | 13 | 2025-12-19 | 9.8 - 10.9 | 9.95 | In |
Put | SMMT Option Put 19-12-2025 30 | 20 | 2025-12-19 | 14.3 - 15.7 | 13.7 | In |
Put | SMMT Option Put 19-12-2025 35 | 17 | 2025-12-19 | 16.8 - 20.5 | 16.2 | In |
Put | SMMT Option Put 19-12-2025 40 | 402 | 2025-12-19 | 22.3 - 24.8 | 21.1 | In |
Put | SMMT Option Put 19-12-2025 50 | 0 | 2025-12-19 | 30.1 - 33.9 | 32.25 | In |
Summit Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Summit Total Stockholder Equity
Total Stockholder Equity |
|
Summit Therapeutics Corporate Management
| Elaine JD | Head Counsel | Profile | |
| Fong Clow | Chief Officer | Profile | |
| Betty Chang | Oncology Research | Profile | |
| Bhaskar Anand | Chief Finance | Profile | |
| Will Black | Head Technology | Profile |
Additional Tools for Summit Stock Analysis
When running Summit Therapeutics' price analysis, check to measure Summit Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Summit Therapeutics is operating at the current time. Most of Summit Therapeutics' value examination focuses on studying past and present price action to predict the probability of Summit Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Summit Therapeutics' price. Additionally, you may evaluate how the addition of Summit Therapeutics to your portfolios can decrease your overall portfolio volatility.